GeneDx Holdings Corp. - Common Stock (WGS)

CUSIP: 81663L200

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
28,736,767
Total 13F shares
31,497,581
Share change
+3,149,039
Total reported value
$2,907,518,951
Put/Call ratio
130%
Price per share
$92.31
Number of holders
227
Value change
+$295,483,780
Number of buys
139
Number of sells
110

Quarterly Holders Quick Answers

What is CUSIP 81663L200?
CUSIP 81663L200 identifies WGS - GeneDx Holdings Corp. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of WGS - GeneDx Holdings Corp. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Eli Casdin
3/4/5
Director, 10%+ Owner
14%
3,880,073
$337,217,143 18 Jun 2025
Casdin Capital, LLC
13F
Company
12%
3,507,164
$310,611,980 31 Mar 2025
13F
Corvex Management LP
3/4/5 13F
Director, 10%+ Owner · Company
8.6%
from 13F
86,811,516
$281,269,312 31 Jan 2023
FMR LLC
13F 13D/G
Company
0.6%
from 13D/G
2,793,953
$247,446,426 31 Mar 2025
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
3/4/5 13D/G
10%+ Owner
4.9%
from 13D/G
2,719,692
$192,487,561 15 Nov 2024
GOLDMAN SACHS GROUP INC
13D/G 13F
THE GOLDMAN SACHS GROUP, INC. · Company
3.9%
1,106,752
$122,860,496 -$34,984,913 31 Mar 2025
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC
13F 13D/G
Company
3%
from 13D/G
1,202,529
$106,501,981 31 Mar 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
4.1%
1,188,988
$105,302,722 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
4%
1,147,355
$101,615,496 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
3.6%
1,031,326
$91,339,387 31 Mar 2025
13F
OPKO HEALTH, INC.
3/4/5
10%+ Owner
class O/S missing
2,646,972
$91,295,123 15 Aug 2024
ORACLE INVESTMENT MANAGEMENT INC
13F
Company
3.4%
969,954
$85,903,976 31 Mar 2025
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
1.9%
557,018
$49,332,299 31 Mar 2025
13F
T. Rowe Price Investment Management, Inc.
13F
Company
1.8%
503,733
$44,614,000 31 Mar 2025
13F
Zweig-DiMenna Associates LLC
13F
Company
1.6%
457,100
$40,483,062 31 Mar 2025
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.6%
454,956
$40,293,179 31 Mar 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.5%
436,900
$38,694,049 31 Mar 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.5%
425,647
$37,697,427 31 Mar 2025
13F
NEXT CENTURY GROWTH INVESTORS LLC
13F
Company
1.5%
417,037
$36,934,881 31 Mar 2025
13F
LORD, ABBETT & CO. LLC
13F
Company
1.4%
409,336
$36,253,000 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
mixed-class rows
866,901
mixed-class rows
$35,497,895 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.4%
392,725
$34,791,466 31 Mar 2025
13F
Invesco Ltd.
13F
Company
1.4%
389,579
$34,503,065 31 Mar 2025
13F
MACQUARIE GROUP LTD
13F
Company
1.3%
362,019
$32,062,000 31 Mar 2025
13F
STATE STREET CORP
13F
Company
1.2%
339,629
$30,079,242 31 Mar 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
1.2%
333,376
$29,524,809 31 Mar 2025
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
1.1%
303,000
$26,835,195 31 Mar 2025
13F
Point72 Asset Management, L.P.
13F
Company
1%
286,971
$25,415,613 31 Mar 2025
13F
GAGNON SECURITIES LLC
13F
Company
0.99%
284,911
$25,233,143 31 Mar 2025
13F
Science & Technology Partners, L.P.
13F
Company
0.96%
276,641
$24,500,710 31 Mar 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.94%
269,602
$23,877,420 31 Mar 2025
13F
FRANKLIN RESOURCES INC
13F
Company
0.78%
222,883
$19,739,665 31 Mar 2025
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
0.77%
222,477
$19,703,676 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.74%
212,466
$18,817,198 31 Mar 2025
13F
Alamea Verwaltungs GmbH
13F
Company
0.73%
211,065
$18,692,972 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.69%
197,912
$17,528,076 31 Mar 2025
13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
13F
Company
0.68%
196,600
$17,411,879 31 Mar 2025
13F
Blackstone Tactical Opportunities Fund - FD L.P.
3/4/5
10%+ Owner
0.35%
100,000
$16,752,000 22 Jul 2021
NORTHERN TRUST CORP
13F
Company
0.64%
185,189
$16,401,264 31 Mar 2025
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.66%
190,297
$16,097,223 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.51%
146,907
$13,010,849 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.51%
145,247
$12,861,909 31 Mar 2025
13F
Nicholas Investment Partners, LP
13F
Company
0.46%
131,610
$11,656,040 31 Mar 2025
13F
Gagnon Advisors, LLC
13F
Company
0.44%
127,062
$11,253,246 31 Mar 2025
13F
OBERWEIS ASSET MANAGEMENT INC/
13F
Company
0.43%
123,500
$10,937,778 31 Mar 2025
13F
Russell Investments Group, Ltd.
13F
Company
0.38%
108,368
$9,597,636 31 Mar 2025
13F
Assenagon Asset Management S.A.
13F
Company
0.37%
106,119
$9,398,429 31 Mar 2025
13F
Telemark Asset Management, LLC
13F
Company
0.35%
100,000
$8,856,500 31 Mar 2025
13F
ASHFORD CAPITAL MANAGEMENT INC
13F
Company
0.33%
94,216
$8,344,240 31 Mar 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.31%
89,775
$7,950,923 31 Mar 2025
13F

Institutional Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q2 2025

As of 30 Jun 2025, GeneDx Holdings Corp. - Common Stock (WGS) was held by 227 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,497,581 shares. The largest 10 holders included Casdin Capital, LLC, Corvex Management LP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, BlackRock, Inc., Pentwater Capital Management LP, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, T. Rowe Price Investment Management, Inc., UBS Group AG, and ORACLE INVESTMENT MANAGEMENT INC. This page lists 228 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
223
Q2 2025 holders
227
Holder diff
4
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.